Cancer Crosslinks 2017
Session 1: Cancer and Inflammation – New Insights and Their Clinical Impact.
Session 2: Today's Cancer Treatment: How Individualized Can it Be?
Session 3: From Data Generation to Clinical Use: Real World Evidence as New Way to Go?
Session 2: Today's Cancer Treatment: How Individualized Can it Be?
Session 3: From Data Generation to Clinical Use: Real World Evidence as New Way to Go?
Event 2017 - Speakers & Topics
Jérôme Galon, Ph.D., Research Director at INSERM; Head of the INSERM Integrative Cancer Immunology Laboratory, Cordeliers Research Center, Paris, France
- Cancer and Inflammation.
Seth B. Coffelt, Head of Immune cells and Metastasis Group, Cancer Research UK
Beatson Institute, Institute of Cancer Sciences, University of Glasgow, UK
Beatson Institute, Institute of Cancer Sciences, University of Glasgow, UK
- Inflammation Lights the Way to Metastasis.
Julian Marchesi, Professor of Digestive Health, Faculty of Medicine, Department of Surgery & Cancer, Imperial College London, UK
- The Gut Microbiota, Inflammation, and Cancer.
William G. Wierda, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA
- Hematological Cancers: How Individualized Can We Treat Patients Today?
Anna Schuh, Director of Molecular Diagnostics in the Department of Oncology; Honorary Consultant Hematologist at Oxford University Hospitals Trust, UK
- The Role of Clinical -omics for Precision Medicine Approaches in Hematology.
Panel Discussion
Moderators: Benedikte Thunes-Akre & Hilde Enserink
Steinar Aamdal, Head Dept. of Early Cancer Trials and Research Support, OUS
Espen Enerly, Researcher, HPV-related Epidemiological Research Unit, The Norwegian Cancer Registry
Ivar Sønbø Kristiansen, Department of Health Management and Health Economics, University of Oslo
Per Harald Fuglerud: Senior Advisor, Statistician; The Norwegian Medicines Agency
Moderators: Benedikte Thunes-Akre & Hilde Enserink
Steinar Aamdal, Head Dept. of Early Cancer Trials and Research Support, OUS
Espen Enerly, Researcher, HPV-related Epidemiological Research Unit, The Norwegian Cancer Registry
Ivar Sønbø Kristiansen, Department of Health Management and Health Economics, University of Oslo
Per Harald Fuglerud: Senior Advisor, Statistician; The Norwegian Medicines Agency
A complete program for Cancer Crosslinks 2017 may be downloaded HERE.
Event 2017 - Sponsors
|
|